Insights

Market commentary and guides

  • Buy Healthscope

    We recommend buying Healthscope following the share price retracing from the recent high and filling the technical price gap down to $2.10.  

  • CYB – Long-term Value

    We continue to see long-term value in CYB following the recent share price correction. Should CYB deliver on its original cost synergy targets, (following…

  • Aristocrat Leisure Reports FY18 Earnings

    Aristocrat Leisure reported a 30% increase in FY18  after tax earnings at A$730m. The result was slightly below consensus and recent digital acquisitions were…

  • Buy Downer EDI – Technical Support

    We recommend buying Downer EDI as the price action begins to find support at the 2018 low of $6.20. The company recently reiterated their…

  • James Hardie – Oversold

    James Hardie is a current holding in the ASX 100 model portfolio and is under  Algo Engine buy conditions. In the last Opportunities in…

  • Gold sell off weighs on Newcrest

    As the US dollar rebounded last night, gold sold off -0.6% to $US 1214. NCM has been under Algo Engine sell signals since forming…

  • Crown, Tabcorp & Star Entertainment

    We highlight the buying interest that is starting to build in Crown, Tabcorp  and Star Entertainment. Crown and Tabcorp are current holdings within our…

  • Amcor – recovery continues

    In our “Opportunities in Review” webinar series, Amcor was identified as a high conviction buy with an upside target of $14.50. The stock has…

  • Buy Healthscope

    Our Algo Engine triggered a buy signal in Healthscope and it remains a current holding in the ASX 100 model portfolio. The retracement in…

  • S&P500 & Global 100

    Our Algo Engine has generated buy signals in the IVV (S&P500) and IOO (Global 100) ETF. We see support building near the current lows.